Company / CapEx per Share
IDEAYA Biosciences, Inc. CapEx per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.03
FY2025
5-year range
$0.01 / $0.06
FY2021-FY2025
Trend
-53.8%
vs FY2024
Sector context
#89 of 192
Health Care
What the data says
At $0.03, IDEAYA Biosciences, Inc.'s capex per share ranks #89 of 192 in the Health Care sector. Declined from $0.05 to $0.03 over the past 2 years.
Based on SEC 10-K filings.
0.03 in FY2025 with a 5-year CAGR of -20.1%.
Declined from $0.05 to $0.03 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +28.9%
- 5-Year CAGR
- -20.1%
- 10-Year CAGR
- -
Sector benchmark
#89 of 192 in Health CareTop 46% of 192This company $0.03 Sector average $2.46
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 53.8% year-over-year.
- Ranks #89 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2017.
- Lowest capex per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.03 | -53.8% |
| FY2024 | $0.06 | +20.7% |
| FY2023 | $0.05 | +284.0% |
| FY2022 | $0.01 | -72.1% |
| FY2021 | $0.05 | -45.5% |
| FY2020 | $0.08 | -22.4% |
| FY2019 | $0.11 | -93.9% |
| FY2018 | $1.79 | -29.3% |
| FY2017 | $2.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026